Literature DB >> 2338283

Towards a better assessment of reflux oesophagitis.

M Guslandi, S Passaretti, A Tittobello.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2338283      PMCID： PMC1378429          DOI： 10.1136/gut.31.4.481

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  6 in total

Review 1.  Histamine-2-receptor antagonists in gastro-oesophageal reflux.

Authors:  D G Colin-Jones
Journal:  Gut       Date:  1989-10       Impact factor: 23.059

2.  Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study.

Authors:  S Sandmark; R Carlsson; O Fausa; L Lundell
Journal:  Scand J Gastroenterol       Date:  1988-06       Impact factor: 2.423

3.  Patterns of gastroesophageal reflux in health and disease.

Authors:  T R Demeester; L F Johnson; G J Joseph; M S Toscano; A W Hall; D B Skinner
Journal:  Ann Surg       Date:  1976-10       Impact factor: 12.969

4.  Daytime gastro-oesophageal reflux is important in oesophagitis.

Authors:  J S de Caestecker; J N Blackwell; A Pryde; R C Heading
Journal:  Gut       Date:  1987-05       Impact factor: 23.059

5.  Pirenzepine in the treatment of reflux oesophagitis. A placebo-controlled, double-blind study.

Authors:  S Niemelä; T Jääskeläinen; J Lehtola; J Martikainen; I Krekelä; S Sarna; H Sarelin
Journal:  Scand J Gastroenterol       Date:  1986-12       Impact factor: 2.423

6.  Ranitidine vs metoclopramide in the medical treatment of reflux esophagitis.

Authors:  M Guslandi; P A Testoni; S Passaretti; E Masci; E Ballarin; U Comin; R Marchi; G Ronchi; A Tittobello
Journal:  Hepatogastroenterology       Date:  1983-06
  6 in total
  1 in total

Review 1.  Diagnosis of reflux disease.

Authors:  N I McDougall
Journal:  Ir J Med Sci       Date:  1996 Jul-Sep       Impact factor: 1.568
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.